Entry level $9.44 = Traget price $9.75 = Stop loss $9.34
Short interest 13.02%
Average analysts price target $27.60 | Overweight
Company profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science...
Huge following. During my spam endeavors, I noticed that the ticker AMRN would bring in several people; much more than was usual. I was always surprised by the large influx of visitors.
That close was also very strong, and so was the daily.
AMRN had a downgrade and had an overreaction to the downgrade it held 20.00 support today. I think it will bounce to $21.00 PM or at open 11.21.19. This alert is only good for this as I don't have a bull or bearish view. I do believe it is worth around $30, I think its undervalued stock but this is a day trade. bought the close around 20.11 avg and a stop loss of...
Ok this stock idea doesnt fit my trading strategy.i was long from 16.7 to the first boom to 19s-20s and panick sold cause i had no idea where this was going to stop.
FUNDUMENTALS.well no introductions needed.Its in a state of euphoria with analysts targets from 30to 50$.
TECHNICALS.Now my reason for trading this.it seems to break over the all time high.
My...
Hi, today we are going to talk about Amarin Corporation and its current landscape.
Amarin puts its Cardiovascular Drug named Vascepa to a key test today by the FDA committee. Back in 2012, the FDA initially approved Vascepa as the medication showed results in reduce triglyceride levels. Today the decision cames to determine if Amarin will be allowed to prescribe...
Amarin had a gap down on July 18th that created an Island Reversal pattern. The stock saw another gap down on August 9th. AMRN has pulled back a couple of times after filling the gap creating a double-bottom & a base for the stock. Once again the stock price is testing the top of this fill level but with stochastics reading overbought I would expect another...
Entry level $17.50 = Target price $20 = Stop loss $16.75
High short interest of 14.45%
Stock is well below its average analyst price target @$29.11.& buy rating.
Company profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program...
Here is a great opportunity to pick up AMRN .
At Three Percent Trades we have a price target of $27.00 / share, which is a potential upside of 68.22%.
We use a combination of fundamentals & technical analysis to trade high probability set-ups, and believe this is a great opportunity to take advantage.
AMRN’s innovation outlook is neutral based on a current score of 42 out of 99, underperforming sector average. Insiders sentiment is negative. Over the past 4 quarters AMRN beat earnings estimates 3 times.
For more analysis and articles visit our website.
AMRN has a consistent horizontal trend between price points $13 and $22. Currently valued at $16.31, AMRN has a great risk/reward opportunity with a possible return of over 40% in the next couple weeks.
AMRN price touched weekly strong support level and also has possibility go to short. wait for abc pattern for long and wait for breakout for short. I also watching this one .
